Bruce I Turetsky Selected Research

amyl acetate (pentyl acetate)

1/2013	Odor hedonic capacity and anhedonia in schizophrenia and unaffected first-degree relatives of schizophrenia patients.
10/2003	Impairment of odor hedonics in men with schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruce I Turetsky Research Topics

Disease

36	Schizophrenia (Dementia Praecox) 01/2022 - 12/2002
5	Psychotic Disorders (Schizoaffective Disorder) 12/2018 - 07/2012
1	Neurodevelopmental Disorders 01/2022
1	Cognitive Dysfunction 01/2021
1	Dementia (Dementias) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020
1	DiGeorge Syndrome (Syndrome, DiGeorge) 12/2018
1	Velopharyngeal Insufficiency 12/2018
1	Prodromal Symptoms 07/2012
1	Mood Disorders (Mood Disorder) 03/2012
1	Ageusia (Hypogeusia) 02/2007

Drug/Important Bio-Agent (IBA)

6	Biological ProductsIBA 12/2019 - 04/2003
6	Antipsychotic Agents (Antipsychotics)IBA 03/2016 - 12/2002
4	Biomarkers (Surrogate Marker)IBA 12/2018 - 11/2009
4	Phenylthiourea (Phenylthiocarbamide)IBA 12/2012 - 04/2005
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 12/2018 - 02/2012
2	Dopamine (Intropin)FDA LinkGeneric 03/2016 - 02/2012
2	Glutamic Acid (Glutamate)FDA Link 10/2015 - 09/2011
2	Genetic Markers (Genetic Marker)IBA 04/2014 - 12/2012
2	amyl acetate (pentyl acetate)IBA 01/2013 - 10/2003
2	citralvaIBA 07/2012 - 02/2009
2	hydroxyisohexyl 3-cyclohexene carboxaldehydeIBA 07/2012 - 02/2009
1	Sp4 Transcription FactorIBA 01/2022
1	AZD8529IBA 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	metabotropic glutamate receptor 2IBA 01/2022
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2021
1	IronIBA 01/2020
1	GTP-Binding Proteins (G-Protein)IBA 03/2016
1	Serotonin (5 Hydroxytryptamine)IBA 03/2016
1	Guanosine Triphosphate (GTP)IBA 03/2016
1	SynaptophysinIBA 10/2015
1	Synapsins (Synapsin I)IBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 10/2015
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2015
1	Adenosine (Adenocard)FDA LinkGeneric 07/2012
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 05/2012
1	Nicotine FDA Link 05/2012
1	N 30IBA 02/2012
1	Indicators and Reagents (Reagents)IBA 11/2009
1	Cyclic AMP (AMP, Cyclic)IBA 02/2009
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 07/2008
1	Ethanol (Ethyl Alcohol)IBA 11/2006
1	Apolipoproteins E (ApoE)IBA 01/2006
1	ApolipoproteinsIBA 01/2006
1	N-Methylaspartate (NMDA)IBA 06/2004
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2004
1	Ketamine FDA LinkGeneric 06/2004
1	Olanzapine (Zyprexa)FDA Link 04/2004
1	Haloperidol (Haldol)FDA LinkGeneric 04/2004

Therapy/Procedure

1	Neurofeedback 01/2020
1	Therapeutics 03/2012